✦ LIBER ✦

5 Influence of an oligodendrogliomal component on the survival of patients with anaplastic astrocytomas: A report of radiation therapy oncology group 83-02

✍ Scribed by B. Donahue; C. Scott; J. Nelson; M. Rotman; K.J. Murray; D. Nelson; F.L. Banker; J.D. Earle; J.A. Fischbach; S.O. Asbell; L.E. Gaspar; A.M. Markoe; W. Curran

Book ID: 108435947
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 126 KB
Volume: 36
Category: Article
ISSN: 0360-3016
DOI: 10.1016/s0360-3016(97)85347-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Influence of an oligodendroglial compone

Influence of an oligodendroglial component on the survival of patients with anaplastic astrocytomas: A report of radiation therapy oncology group 83-02

✍ Bernadine Donahue; Charles B. Scott; James S. Nelson; Marvin Rotman; Kevin J. Mu 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 329 KB

Radiation therapy oncology group (rtog)

Radiation therapy oncology group (rtog) survival data on anaplastic astrocytomas of the brain: Does a more aggressive form of treatment adversely impact survival?

✍ G.E. Laramore; K.L. Martz; J.S. Nelson; T.W. Griffin; C.H. Chang; J. Horton 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 712 KB

Quality-adjusted survival analysis of ma

Quality-adjusted survival analysis of malignant glioma. Patients treated with twice-daily radiation (RT) and carmustine: A report of radiation therapy oncology group (RTOG) 83-02

✍ Kevin J. Murray; Diana F. Nelson; Charles Scott; A.Jennifer Fischbach; Arthur Po 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 809 KB

Quality adjusted survival analysis of ma

Quality adjusted survival analysis of malignant glioma patients treated with twice-daily radiation (RT) and carmustine: A report of radiation therapy oncology group (RTOG) 83-02

✍ Kevin J. Murray; Diana F. Nelson; Steven Isaacson; Charles Scott; Jennifer A. Fi 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Survival comparison of radiosurgery elig

Survival comparison of radiosurgery eligible and ineligible malignant glioma patients treated with hyperfractionated radiation therapy (RT) and BCNU: a report of radiation therapy oncology group (RTOG) 83-02

✍ W.J. Curran Jr; C.B. Scott; J.S Nelson; L.A. Martin; A.S. Weinstein; T.L. Philli 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 102 KB

Central pathology review in clinical tri

Central pathology review in clinical trials for patients with malignant glioma. A report of radiation therapy oncology group 83-02

✍ Charles B. Scott; James S. Nelson; Nancy C. Farnan; Walter J. Curran Jr.; Kevin 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 617 KB